Schaper Benz & Wise Investment Counsel Inc. WI Sells 601 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Schaper Benz & Wise Investment Counsel Inc. WI cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 17.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,896 shares of the company’s stock after selling 601 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in GE HealthCare Technologies were worth $226,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. United Community Bank lifted its stake in GE HealthCare Technologies by 2,891.9% in the fourth quarter. United Community Bank now owns 1,107 shares of the company’s stock valued at $87,000 after buying an additional 1,070 shares during the period. Amundi increased its stake in shares of GE HealthCare Technologies by 45.9% in the 4th quarter. Amundi now owns 1,726,902 shares of the company’s stock valued at $148,963,000 after acquiring an additional 542,944 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of GE HealthCare Technologies by 21.2% during the 4th quarter. Larson Financial Group LLC now owns 3,807 shares of the company’s stock valued at $298,000 after acquiring an additional 665 shares during the period. Machina Capital S.A.S. bought a new position in GE HealthCare Technologies during the fourth quarter worth $765,000. Finally, Andra AP fonden increased its stake in GE HealthCare Technologies by 431.6% in the fourth quarter. Andra AP fonden now owns 50,500 shares of the company’s stock valued at $3,948,000 after purchasing an additional 41,000 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $86.58 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a fifty day moving average price of $86.77 and a 200-day moving average price of $86.15. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The firm has a market cap of $39.59 billion, a price-to-earnings ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on GEHC shares. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.